Tags

Type your tag names separated by a space and hit enter

Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
Vaccine. 2019 01 07; 37(2):223-225.V

Abstract

This article presents the World Health Organization's (WHO) recommendations on the use of hepatitis B vaccines excerpted from the Hepatitis B vaccines: WHO position paper, July 2017, published in the Weekly Epidemiological Record (Hepatitis B vaccines, 2017) [1]. This position paper replaces the May 2009 WHO position paper on hepatitis B vaccines (Hepatitis B vaccines, 2009) [2]. The position paper gives updated information on hepatitis B vaccines and their storage, transport and deployment. The recommendations concern the target groups for vaccination and the appropriate schedules. In particular, the recommendations stress the importance of vaccination of all infants at birth as the most effective intervention for the prevention of hepatitis B virus-associated disease worldwide. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of hepatitis B vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/.

Authors+Show Affiliations

World Health Organization, Immunization, Vaccines and Biologicals, 20 Ave Appia, CH-1211 Geneva 27, Switzerland. Electronic address: sageexecsec@who.int.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28743487

Citation

World Health Organization, . "Hepatitis B Vaccines: WHO Position Paper, July 2017 - Recommendations." Vaccine, vol. 37, no. 2, 2019, pp. 223-225.
World Health Organization . Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2019;37(2):223-225.
World Health Organization, . (2019). Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine, 37(2), 223-225. https://doi.org/10.1016/j.vaccine.2017.07.046
World Health Organization . Hepatitis B Vaccines: WHO Position Paper, July 2017 - Recommendations. Vaccine. 2019 01 7;37(2):223-225. PubMed PMID: 28743487.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. A1 - World Health Organization,, Y1 - 2017/07/22/ PY - 2017/07/07/received PY - 2017/07/13/accepted PY - 2017/7/27/pubmed PY - 2019/8/14/medline PY - 2017/7/27/entrez KW - BCG KW - Birth dose KW - HBV KW - Health policy KW - Hepatitis B vaccines KW - Hepatitis B virus KW - Immunization programmes KW - OPV KW - Position paper KW - WHO SP - 223 EP - 225 JF - Vaccine JO - Vaccine VL - 37 IS - 2 N2 - This article presents the World Health Organization's (WHO) recommendations on the use of hepatitis B vaccines excerpted from the Hepatitis B vaccines: WHO position paper, July 2017, published in the Weekly Epidemiological Record (Hepatitis B vaccines, 2017) [1]. This position paper replaces the May 2009 WHO position paper on hepatitis B vaccines (Hepatitis B vaccines, 2009) [2]. The position paper gives updated information on hepatitis B vaccines and their storage, transport and deployment. The recommendations concern the target groups for vaccination and the appropriate schedules. In particular, the recommendations stress the importance of vaccination of all infants at birth as the most effective intervention for the prevention of hepatitis B virus-associated disease worldwide. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of hepatitis B vaccines were discussed by SAGE in October 2016; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2016/October/presentations_background_docs/en/. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/28743487/Hepatitis_B_vaccines:_WHO_position_paper_July_2017___Recommendations_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(17)30954-4 DB - PRIME DP - Unbound Medicine ER -